FMRF Combined With 30% SSA in the Treatment of Rosacea

NACompletedINTERVENTIONAL
Enrollment

15

Participants

Timeline

Start Date

December 1, 2023

Primary Completion Date

November 14, 2024

Study Completion Date

November 14, 2024

Conditions
Rosacea
Interventions
DEVICE

Gold micro needles

The treatment (with gold microneedles) was administered on the day of enrollment after the completion of the detection items. Follow-up visits were conducted at 1 week, 2 weeks, 4 weeks, 8 weeks, 12 weeks. The follow-up contents included visia photography, camera photography, non-invasive skin examination, questionnaire assessment, etc. The study duration was 12 weeks.

DRUG

Gold micro-needles combined with salicylic acid

On the day of enrollment, the treatment was administered (gold microneedle + 30% salicylic acid on half of the face) after the completion of the detection items. A site follow-up was conducted one week later, and a follow-up was carried out two weeks later with the second acid brushing treatment. A follow-up was conducted four weeks later with the third acid brushing treatment. Follow-up was also conducted at the eighth and twelfth weeks. The follow-up contents included: Visia photography, camera photography, non-invasive skin examination, questionnaire assessment, etc. The study duration was 12 weeks.

Trial Locations (1)

710000

The Second Affiliated Hospital of Xi'an Jiaotong University, Xi'an

All Listed Sponsors
lead

Second Affiliated Hospital of Xi'an Jiaotong University

OTHER

NCT06969300 - FMRF Combined With 30% SSA in the Treatment of Rosacea | Biotech Hunter | Biotech Hunter